- 询价
- MedChemExpress(MCE)
- 美国
- HY-143245
- 2025年12月05日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 技术资料
- 保存条件：
Please store the product under the recommended conditions in the Certificate of Analysis.
- 库存：
货期：询盘
- 供应商：
MedChemExpress LLC
- CAS号：
2807477-26-3
- 规格：
询盘
Monoamine Oxidase B inhibitor 2
产品活性：Monoamine Oxidase B inhibitor 2 是一种有效、可逆，具有口服活性的和选择性的单胺氧化酶 B (MAO-B) 抑制剂，IC50 为 1.33 nM。Monoamine Oxidase B inhibitor 2 具有抗氧化和抗神经炎症活性。Monoamine Oxidase B inhibitor 2 可以穿过血脑屏障 (BBB)，可用于帕金森病研究。
产品来源： www.medchemexpress.cn/monoamine-oxidase-b-inhibitor-2.html
研究领域：Neuronal Signaling
作用靶点：Monoamine Oxidase
In Vitro: In cellular experiments, Monoamine Oxidase B inhibitor 2 (compound 8f; 0.5-10.0 μM) could significantly decrease the production of NO and TNF-α in LPS-stimulated BV-2 cells.
In Vivo: In
In Vivo acute and subacute MPTP-induced mice model of Parkinson’s disease, Monoamine Oxidase B inhibitor 2 (compound 8f; 6.3-39.5 mg/kg; oral administration) could significantly improve most behavioral disorders, restore the dopamine content and decrease the MDA content in the mice striatum.
相关产品：β-Aminopropionitrile | Rosmarinic acid | Tranylcypromine hemisulfate | Clorgyline hydrochloride | GSK-LSD1 dihydrochloride | Methylene Blue | Hypericin | Paeonol | Selegiline hydrochloride | Pargyline | (2-Chloropyridin-4-yl)methanamine hydrochloride | Phenelzine sulfate | Hydroxylamine hydrochloride | Moclobemide | Rasagiline | (E/Z)-J147 | PXS-5153A monohydrochloride | Lenumlostat | PXS-4728A | Iproniazid | Contezolid | Norharmane | OG-L002 | Vafidemstat | Safinamide | LOX-IN-3 | Simtuzumab
产品活性：Monoamine Oxidase B inhibitor 2 是一种有效、可逆，具有口服活性的和选择性的单胺氧化酶 B (MAO-B) 抑制剂，IC50 为 1.33 nM。Monoamine Oxidase B inhibitor 2 具有抗氧化和抗神经炎症活性。Monoamine Oxidase B inhibitor 2 可以穿过血脑屏障 (BBB)，可用于帕金森病研究。
产品来源： www.medchemexpress.cn/monoamine-oxidase-b-inhibitor-2.html
研究领域：Neuronal Signaling
作用靶点：Monoamine Oxidase
In Vitro: In cellular experiments, Monoamine Oxidase B inhibitor 2 (compound 8f; 0.5-10.0 μM) could significantly decrease the production of NO and TNF-α in LPS-stimulated BV-2 cells.
In Vivo: In
In Vivo acute and subacute MPTP-induced mice model of Parkinson’s disease, Monoamine Oxidase B inhibitor 2 (compound 8f; 6.3-39.5 mg/kg; oral administration) could significantly improve most behavioral disorders, restore the dopamine content and decrease the MDA content in the mice striatum.
相关产品：β-Aminopropionitrile | Rosmarinic acid | Tranylcypromine hemisulfate | Clorgyline hydrochloride | GSK-LSD1 dihydrochloride | Methylene Blue | Hypericin | Paeonol | Selegiline hydrochloride | Pargyline | (2-Chloropyridin-4-yl)methanamine hydrochloride | Phenelzine sulfate | Hydroxylamine hydrochloride | Moclobemide | Rasagiline | (E/Z)-J147 | PXS-5153A monohydrochloride | Lenumlostat | PXS-4728A | Iproniazid | Contezolid | Norharmane | OG-L002 | Vafidemstat | Safinamide | LOX-IN-3 | Simtuzumab
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
技术资料暂无技术资料 索取技术资料
Monoamine Oxidase B inhibitor 2,2807477-26-3
询价
